Intensity modulated radiotherapy for localized prostate cancer: Rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?

Radiation Oncology

Volumn 2, Issue 1, 2007, Pages

  Chen, Michael J ^a   Weltman, Eduardo ^a,b   Hanriot, Rodrigo M ^a   Luz, Fábio P ^a   Cecílio, Paulo J ^a   da Cruz, José C ^a   Moreira, Frederico R ^a   Santos, Adriana S ^a   Martins, Lidiane C ^a   Nadalin, Wladmir ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; HUMAN; HYPERTENSION; INTENSITY MODULATED RADIATION THERAPY; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; PROSTATECTOMY; RADIATION INJURY; RADIATION RESPONSE; RISK; RISK FACTOR; TREATMENT OUTCOME;

AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RISK; RISK FACTORS; TREATMENT OUTCOME;

EID: 34248396716     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-2-6     Document Type: Article

References (24)

1. HDanks GE Martz KL Diamond JJ The effect of dose on local control of prostate cancer Int J Radiat Oncol Biol Phys 1988 15 6 1299-305 3198435
2. Zelefsky MJ Leibel SA Gaudin PB Kutcher GJ Fleshner NE Venkatramen ES Reuter VE Fair WR Ling CC Fuks Z Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 3 491-500 1998 Jun 1 10.1016/ S0360-3016(98)00091-1 9635694
3. Hanks GE Hanlon AL Schultheiss TE Pinover WH Movsas B Epstein BE Hunt MA Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions Int J Radiat Oncol Biol Phys 41 3 501-10 1998 Jun 1 10.1016/S0360-3016(98)00089-3 9635695
4. Pollack A Zagars GK Starkschall G Antolak JA Lee JJ Huang E von Eschenbach AC Kuban DA Rosen I Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 5 1097-105 2002 Aug 1 10.1016/S0360-3016(02)02829-8 12128107
5. Pollack A Zagars GK Starkschall G Childress CH Kopplin S Boyer AL Rosen II Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity Int J Radiat Oncol Biol Phys 34 3 555-64 1996 Feb 1 10.1016/0360-3016(95)02103-5 8621278
6. Boersma LJ van den Brink M Bruce AM Shouman T Gras L te Velde A Lebesque JV Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms Int J Radiat Oncol Biol Phys 41 1 83-92 1998 Apr 1 10.1016/S0360-3016(98)00037-6 9588921
7. Zelefsky MJ Fuks Z Hunt M Lee HJ Lombardi D Ling CC Reuter VE Venkatraman ES Leibel SA High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 2001 166 3 876-81 10.1016/S0022-5347(05)65855-7 11490237
8. Shu HK Lee TT Vigneauly E Xia P Pickett B Phillips TL Roach M Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer Urology 2001 57 1 102-7 10.1016/S0090-4295(00)00890-6 11164152
9. Zelefsky MJ Fuks Z Happersett L Lee HJ Ling CC Burman CM Hunt M Wolfe T Venkatraman ES Jackson A Skwarchuk M Leibel SA Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 2000 55 3 241-9 10.1016/S0167-8140(99)00100-0 10869739
10. Gleason DF Histologic grading and clinical staging of prostate carcinoma Urologic pathology: The prostate Philadelphia: Lea & Febiger Tannenbaum M 1977 171-97
11. American Joint Comission on Staging of Cancer Manual for staging of cancer Philadelphia: JB Lippincott 5 1997
12. Bolla M Gonzalez D Warde P Dubois JB Mirimanoff RO Storme G Bernier J Ku-ten A Sternberg C Gil T Collette L Pierart M Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 5 295-300 1997 Jul 31 10.1056/ NEJM199707313370502 9233866
13. Emami B Lyman J Brown A Coia L Goitein M Munzenrider JE Shank B Solin LJ Wesson M Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 1 109-22 1991 May 15 2032882
14. Cox JD Stetz J Pajak TF Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 5 1341-6 1995 Mar 30 10.1016/0360-3016(95)00060-C 7713792
15. Acute Radiation Morbidity Scoring Criteria http://www.rtog.org/members/ toxicity/acute.html
16. RTOG/EORTC Late Radiation Morbidity Scoring Schema http://www.rtog.org/ members/toxicity/late.html
17. Mehta CR Patel NR Exact logistic regression: Theory and examples Stat Med 14 19 2143-60 1995 Oct 15 8552893
18. Teh BS Mai WY Augspurger ME Uhl BM McGary J Dong L Grant WH 3rd Lu HH Woo SY Carpenter LS Chiu JK Butler EB Intensity modulated radiation therapy (IMRT) following prostatectomy: More favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer Int J Radiat Oncol Biol Phys 49 2 465-72 2001 Feb 1 10.1016/ S0360-3016(00)01474-7 11173142
19. Zelefsky MJ Fuks Z Hunt M Yamada Y Marion C Ling CC Amols H Venkatraman ES Leibel SA High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 5 1111-6 2002 Aug 1 10.1016/ S0360-3016(02)02857-2 12128109
20. De Meerleer G Vakaet L Meersschout S Villeirs G Verbaeys A Oosterlinck W De Neve W Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients Int J Radiat Oncol Biol Phys 60 3 777-87 2004 Nov 1 10.1016/j.ijrobp.2004.04.017 15465194
21. Brabbins D Martinez A Yan D Lockman D Wallace M Gustafson G Chen P Vicini F Wong J A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: Analysis of chronic toxicity Int J Radiat Oncol Biol Phys 61 2 400-8 2005 Feb 1 10.1016/j.ijrobp.2004.06.001 15667959
22. Pollack A Hanlon A Horwitz EM Feigenberg S Uzzo RG Price RA Radiation therapy dose escalation for prostate cancer: A rationale for IMRT World J Urol 2003 21 4 200-8 10.1007/s00345-003-0356-x 12961097
23. Fiorino C Cozzarini C Vavassori V Sanguineti G Bianchi C Cattaneo GM Foppiano F Magli A Piazzolla A Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions Radiother Oncol 2002 64 1 1-12 10.1016/S0167-8140(02)00147-0 12208568
24. Herold DM Hanlon AL Hanks GE Diabetes mellitus: A predictor for late radiation morbidity Int J Radiat Oncol Biol Phys 43 3 475-9 1999 Feb 1 10.1016/S0360-3016(98)00460-X 10078625